Posts in tag

stroke


Debbie Rigby takes a look at the latest in research news Update on Asthma–COPD Overlap Clinical features of asthma and COPD may represent around 25% of patients with COPD and …

Pharmacists are well-placed to educate at-risk patients about the different types of stroke, provide advice on the major risk factors and related lifestyle choices, as well as drug treatments for …

Debbie Rigby takes a look at the latest in research news Drugs in secondary stroke prevention Aspirin, clopidogrel, or a combination of aspirin with dipyridamole are first-line options for secondary …

For yet another week, vaccination was a key issue in pharmacy headlines; also making the news were pharmacists in emergency settings, and off-label use of doxylamine Federal Health Minister Greg …

Adding an emergency medicine pharmacist to a stroke call-out team showed a marked difference in treatment times Researchers from Monash University’s Pharmacy Department (Faculty of Pharmacy and Pharmaceutical Sciences), the …

Debbie Rigby takes a look at the latest in research news Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke A UK population-based cohort study and linked …

Ben Basger takes a look at the modifiable risk factors for stroke A recent Australian study reported that low education is associated with increased stroke risk, (BMJ Open 2018. doi:10.1136/bmjopen-2018-024070) …

A stroke is a life-threatening emergency, writes Louis Roller A stroke, previously known medically as a cerebrovascular accident (CVA), is the rapidly developing loss of brain function(s) due to disturbance …

Jarrod McMaugh takes a look at the patient perspective regarding stroke… and how pharmacists can help The pathophysiology of stroke is one that pharmacists are familiar with, and does not …

Are CVD-related deaths going up or down? Here’s the latest based on data collected between 1980 and 2015 1. Death rates from cardiovascular disease have fallen considerably since the late …

A relatively new drug has been found to greatly reduce risk of cardiovascular and kidney disease – though it comes with risks of its own Canagliflozin (Invokana) is a SGLT2 …

Australia’s houses are so poorly designed that they contribute to deaths over winter, one expert has warned Professor Adrian Barnett, Senior Research Fellow at the Queensland University of Technology, says …